Bacteriology

  1. Scheme (click for more info)
    Examinations
    Sample Format
    Distributions per year
    Samples per distribution
    Scoring
  2. Presence and absence of AAFB bacilli using ZN or immunofluorescence
    Fixed smear of sputum
    3
    4
    Presence or absence of AAFB bacilli
  3. Determination of antimicrobial susceptibilities to the appropriate antibiotics according to clinical site stated
    Freeze dried pure cultures
    12
    2
    Susceptibility profile results interpreted as susceptible, intermediate and resistant
  4. Bacterial Identification
  5. Identification of the organism, presence of a resistance mechanism and the carbapenemase gene present.
    Simulated liquid rectal swab
    4
    2
    Full scores given for species level identification for core pathogens and presence or absence of a CPO.
  6. Detection of toxigenic Clostridioides difficile. Typing results are collected but not scored.
    Simulated freeze dried liquid faecal samples
    4
    2
    Presence of toxigenic C. difficile and /or toxin
  7. Isolation and identification of bacterial pathogens Susceptibility testing of pure cultures Clinical details are provided with each specimen Suitable for conventional and molecular methods
    Two freeze dried simulated clinical specimens for identification and two freeze dried pure cultures for susceptibility
    4
    4
    Organisms are classified as core or advanced with full scores given for species level identification for core pathogens and genus level identification for advanced pathogens. Susceptibility profile results interpreted as susceptible, intermediate and resistant
  8. Isolation and identification Clinical details are provided with each specimen. Provided as a start-up scheme for a laboratory examining this sample type and new to EQA participation
    Simulated freeze dried faecal specimens
    1
    4
    Organisms are classified as core or advanced with full scores given for species level identification for core pathogens and genus level identification for advanced pathogens
  9. Isolation and identification of bacterial pathogens Suitable for conventional, molecular and MALDI-ToF MS Clinical details are provided with each specimen
    Simulated freeze dried clinical specimens
    12
    3
    Organisms are classified as core or advanced with full scores given for species level identification for core pathogens and genus level identification for advanced pathogens
  10. Isolation, identification, and if appropriate determination of antimicrobial susceptibilities Clinical details are provided with each specimen
    Simulated freeze dried genital clinical specimens
    3
    2
    Organisms are classified as core or advanced with full scores given for species level identification for core pathogens and genus level identification for advanced pathogens. Susceptibility profile results interpreted as susceptible, intermediate and resistant
  11. Direct and post culture detection of mycobacteria and rifampicin resistance genes using molecular methods Genotyping results are also collated and presented for in-house comparisons but not scored
    Freeze dried simulated sputum
    3
    2
    Presence or absence of Mycobacteria and rifampicin resistance
  12. Detection of Chlamydia trachomatis & Neisseria gonorrhoeae
    Simulated endocervical swab and urine
    3
    4
    Presence or absence of Chlamydia trachomatis & Neisseria gonorrhoeae
  13. Detection of MRSA by conventional and molecular method
    Simulated freeze dried clinical specimens
    4
    2
    Presence or absence of MRSA
  14. Detection of mycobacteria by culture
    Freeze dried simulated sputum
    3
    4
    Presence or absence of a Mycobacterium sp.
  15. Detection of Legionella pneumophila and pneumococcal antigens in urine
    Urine
    3
    3
    Presence or absence of Legionella pneumophila and pneumococcal antigens